Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of immunotherapy

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CJI.0b013e3181cc263bPMID 20386465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

  2009cited by this paper
• Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy

  2009influential reference
• Cytotoxic T lymphocytes as immune‐therapy in haematological practice

  2008cited by this paper
• Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy

  2008cited by this paper
• Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation

  2008influential reference
• Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

  2007cited by this paper
• Capture and generation of adenovirus specific T cells for adoptive immunotherapy

  2007cited by this paper
• Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.

  2007cited by this paper
• Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

  2006cited by this paper
• Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

  2006cited by this paper
• Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases

  2006cited by this paper
• Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins.

  2006cited by this paper
• Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation

  2005cited by this paper
• Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation

  2005cited by this paper
• Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients.

  2005cited by this paper
• Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery

  2005cited by this paper
• Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants.

  2004cited by this paper
• CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection

  2004cited by this paper
• Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.

  2004cited by this paper
• Analysis of antigen-specific T-cell responses with synthetic peptides--what kind of peptide for which purpose?

  2004cited by this paper
• Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study

  2003cited by this paper
• Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.

  2002cited by this paper
• Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.

  2002cited by this paper
• Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

  2002cited by this paper
• Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation.

  2001cited by this paper
• Immunological Aspects of Haploidentical Stem Cell Transplantation in Children

  2001cited by this paper
• Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.

  2001cited by this paper
• CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

  2000cited by this paper
• Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?

  2000cited by this paper
• Status of Cytomegalovirus Prevention and Treatment in 2000.

  2000cited by this paper
• Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

  1998cited by this paper
• Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

  1998cited by this paper
• Prevention of EBV‐induced B‐lymphoproliferative disorder by ex vivo marrow B‐cell depletion in HLA‐phenoidentical or non‐identical T‐depleted bone marrow transplantation

  1998cited by this paper
• High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

  1998cited by this paper
• Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

  1995cited by this paper
• Donor T cells to treat EBV-associated lymphoma.

  1994cited by this paper
• Increasing incidence of adenovirus disease in bone marrow transplant recipients.

  1994cited by this paper
• Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation.

  1994cited by this paper

• [European Pharmacovigilance of Advanced Therapy Medicinal Products].

  2025cites this paper
• Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy

  2022cites this paper
• Study of mechanisms of cell death induction by the essential oil Aloysia citriodora and its major component, citral, and evaluation of their potential synergistic effects with oxaliplatin in human colon cancer cells

  2021cites this paper
• Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications

  2021cites this paper
• Adenoviruses

  2019cites this paper
• Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study.

  2018cites this paper
• Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT

  2018cites this paper
• Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial

  2017influential citation
• Adoptive Cellular Immunotherapy for the treatment of refractory Adenovirus infections after Hematopoietic Stem Cell Transplantation : From bench to bedside

  2017cites this paper
• Mécanismes d'action et de résistance des Adénovirus C au Brincidofovir

  2017cites this paper
• Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-&ggr; Immunomagnetic Selection

  2016cites this paper
• Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms

  2016cites this paper
• Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

  2016cites this paper
• Human Adenovirus, Polyomavirus, and Parvovirus Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Paediatric immune reconstitution with adenovirus adoptive immunotherapy post haematopoietic stem cell transplant

  2016cites this paper
• Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells

  2014influential citation
• Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.

  2014cites this paper
• Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.

  2014cites this paper
• Management of Adenovirus in Children after Allogeneic Hematopoietic Stem Cell Transplantation

  2013cites this paper
• Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.

  2012cites this paper
• Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients

  2012cites this paper
• The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation.

  2012cites this paper
• Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients.

  2012cites this paper
• Traitement par lymphothérapie adoptive des infections virales chez les patients transplantés : de réelles raisons d’espérer

  2012cites this paper
• Apport des méthodes d’isolement immunomagnétique de lymphocytes T cytotoxiques dans la restauration rapide d’une immunité antivirale après allogreffe de cellules souches hématopoïétiques

  2012cites this paper
• Adoptive immunotherapy with virus-specific T cells.

  2011cites this paper
• Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients.

  2011cites this paper
• The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.

  2011cites this paper
• Induction of Antiviral Cytotoxic T Cells by Plasmacytoid Dendritic Cells for Adoptive Immunotherapy of Posttransplant Diseases

  2011cites this paper
• How I treat adenovirus in hematopoietic stem cell transplant recipients.

  2010cites this paper
• Low influence of irradiation on the functional activity of in-vitro expanded ADV-specific T cells

  2010cites this paper
• Comparison of In-House Real-Time Quantitative PCR to the Adenovirus R-Gene Kit for Determination of Adenovirus Load in Clinical Samples

  2010cites this paper
• Reconstitution immunitaire et immunothérapie adoptive anti-virales après allogreffe de cellules souches hématopoiétiques

  2010cites this paper